Uncategorized
Letter to the Editor
To the Editor:I am submitting a counterpoint to the apologetics provided by Drs. Gustafson and Lindstrom regarding the pricing of Omidria in the Nov. 10, 2015, issue of Ocular Surgery News. I offer some “outside of the beltway” perspective, characterized by Allison Weber Shuren, MSN, JD, as “misguided” at the 2015 ACES/SEE meeting. Please note that all three are paid consultants to Omeros.